Oladunni Oluwoye1, Hailey Reneau, Jalene Herron, Karl C Alcover, Sterling McPherson, John Roll, Michael G McDonell. 1. Initiative for Research and Education to Advance Community Health, Washington State University, Spokane, WA (OO, HR, JH, KCA, MGM); Elson S. Floyd College of Medicine, Washington State University, Spokane, WA (OO, SM, JR, MGM); Program for Excellence in Addiction Research, Washington State University, Spokane, WA (OO, SM, JR, MGM); Providence Medical Research Center, Providence Health Care, Spokane, WA (SM).
Abstract
INTRODUCTION: Monitoring devices provide a platform for assessing alcohol use and implementing alcohol interventions. This pilot study focused on assessing the early-stage feasibility and usability of a smartphone-based application and breathalyzer used in a contingency management intervention for alcohol use. METHODS: Six nontreatment-seeking participants completed a 9-week ABA within-subjects designed intervention targeting alcohol use. Participants submitted 2 to 8 alcohol breathalyzer samples per day and completed self-report drinking measures and usability assessments. During the A phases (weeks 1-3 and 8-9), participants received reinforces for submitting breathalyzer samples, regardless of their results. During the contingency management, B phase (weeks 4-7), and received reinforcers only when negative breathalyzer samples were submitted. Usability assessment of the application was also conducted during weeks 2 and 9. RESULTS: Participants in the contingent B phase (49%) were more likely to submit alcohol-negative breathalyzer samples compared with the noncontingent A phases (27%; P < 0.001). Usability assessment of the application varied, and participants noted several technical concerns. CONCLUSION: The use of smartphones and breathalyzers may be a practical solution to extend the reach of contingency management during and after treatment.
INTRODUCTION: Monitoring devices provide a platform for assessing alcohol use and implementing alcohol interventions. This pilot study focused on assessing the early-stage feasibility and usability of a smartphone-based application and breathalyzer used in a contingency management intervention for alcohol use. METHODS: Six nontreatment-seeking participants completed a 9-week ABA within-subjects designed intervention targeting alcohol use. Participants submitted 2 to 8 alcohol breathalyzer samples per day and completed self-report drinking measures and usability assessments. During the A phases (weeks 1-3 and 8-9), participants received reinforces for submitting breathalyzer samples, regardless of their results. During the contingency management, B phase (weeks 4-7), and received reinforcers only when negative breathalyzer samples were submitted. Usability assessment of the application was also conducted during weeks 2 and 9. RESULTS: Participants in the contingent B phase (49%) were more likely to submit alcohol-negative breathalyzer samples compared with the noncontingent A phases (27%; P < 0.001). Usability assessment of the application varied, and participants noted several technical concerns. CONCLUSION: The use of smartphones and breathalyzers may be a practical solution to extend the reach of contingency management during and after treatment.
Authors: John M Roll; Nancy M Petry; Maxine L Stitzer; Mary L Brecht; Jessica M Peirce; Michael J McCann; Jack Blaine; Marilyn MacDonald; Joan DiMaria; Leroy Lucero; Scott Kellogg Journal: Am J Psychiatry Date: 2006-11 Impact factor: 18.112
Authors: Michael G McDonell; Jordan Skalisky; Emily Leickly; Michael F Orr; Sterling McPherson; John Roll; Nathalie Hill-Kapturczak; Martin Javors Journal: Psychol Addict Behav Date: 2017-07-17
Authors: Gregory E Skipper; Natasha Thon; Robert L DuPont; Michael D Campbell; Wolfgang Weinmann; Friedrich M Wurst Journal: Eur Addict Res Date: 2013-12-04 Impact factor: 3.015
Authors: Martin A Javors; Nathalie Hill-Kapturczak; John D Roache; Tara E Karns-Wright; Donald M Dougherty Journal: Alcohol Clin Exp Res Date: 2016-04-30 Impact factor: 3.455
Authors: Crystal L Smith; Nicole M Rodin; Julie Y Hwang; André Q C Miguel; Kim Johnson; Michael G McDonell; Sterling M McPherson Journal: Addict Sci Clin Pract Date: 2022-03-26
Authors: Lara N Coughlin; Erin E Bonar; Maureen A Walton; Anne C Fernandez; Isabelle Duguid; Inbal Nahum-Shani Journal: Front Digit Health Date: 2022-02-28
Authors: Gary M Reisfield; Scott A Teitelbaum; Joseph T Jones; Dana Mason; Max Bleiweis; Ben Lewis Journal: J Anal Toxicol Date: 2021-11-09 Impact factor: 3.367